Fgfr1 regulates development through the combinatorial use of signaling proteins

Area of Science:

• Cellular signaling
• Developmental biology
• Molecular genetics

Background:

• Fibroblast growth factor (Fgf) signaling is crucial for development and disease.
• Erk1/2 pathway activation via Frs2 is considered the primary downstream effector of Fgf receptors (Fgfrs).
• Fgfrs possess alternative signaling mechanisms beyond Frs2.

Purpose of the Study:

• To investigate the functional importance of the complete spectrum of Fgfr signaling.
• To elucidate the roles of various downstream signaling proteins in Fgf-mediated processes.
• To understand the additive and independent contributions of different Fgf signaling pathways.

Main Methods:

• Engineering a series of knock-in point mutations in mouse Fgfr1 to individually and combinatorially disrupt signaling functions.
• Analyzing the developmental and biochemical consequences of specific Fgfr1 mutations.
• Comparing mutant phenotypes to Fgfr1-null models.

Main Results:

• Frs2 binding to Fgfr1 demonstrates the most widespread developmental functions.
• Fgfr1 signaling involves multiple proteins acting additively in vivo.
• Crk proteins and Plcγ contribute to Erk1/2 activation, influencing axis elongation, craniofacial, and limb development.
• Disrupting known signaling functions reduced Erk1/2 and Plcγ activation but did not fully replicate the peri-implantation Fgfr1-null phenotype.

Conclusions:

• Fgfr1 signaling is pleiotropic and relies on additive contributions from multiple downstream proteins.
• Erk1/2 activation is influenced by Frs2, Crk, and Plcγ, highlighting complex signaling integration.
• Erk1/2-independent pathways are essential for Fgf signaling in vivo, particularly during early development.